The Association for Accessible Medicines is highlighting to the Senate Finance Committee the factors that contributed to the resiliency of the generic drug supply chain throughout the COVID-19 crisis.
Akorn said it will continue to operate as usual throughout the duration of the Chapter 11 and sale process, including meeting its contractual obligations and making payments to vendors.